14 research outputs found
Chemical Insight into the Emergence of Influenza Virus Strains That Are Resistant to Relenza
A reagent
panel containing ten 4-substituted 4-nitrophenyl α-d-sialosides and a second panel of the corresponding sialic
acid glycals were synthesized and used to probe the inhibition mechanism
for two neuraminidases, the N2 enzyme from influenza type A virus
and the enzyme from <i>Micromonospora viridifaciens</i>.
For the viral enzyme the logarithm of the inhibition constant (<i>K</i><sub>i</sub>) correlated with neither the logarithm of
the catalytic efficiency (<i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub>) nor catalytic proficiency (<i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub><i>k</i><sub>un</sub>). These linear free energy relationship data support the
notion that these inhibitors, which include the therapeutic agent
Relenza, are not transition state mimics for the enzyme-catalyzed
hydrolysis reaction. Moreover, for the influenza enzyme, a correlation
(slope, 0.80 ± 0.08) is observed between the logarithms of the
inhibition (<i>K</i><sub>i</sub>) and Michaelis (<i>K</i><sub>m</sub>) constants. We conclude that the free energy
for Relenza binding to the influenza enzyme mimics the enzyme–substrate
interactions at the Michaelis complex. Thus, an influenza mutational
response to a 4-substituted sialic acid glycal inhibitor can weaken
the interactions between the inhibitor and the viral neuraminidase
without a concomitant decrease in free energy of binding for the substrate
at the enzyme-catalyzed hydrolysis transition state. The current findings
make it clear that new structural motifs and/or substitution patterns
need to be developed in the search for a bona fide influenza viral
neuraminidase transition state analogue inhibitor
Neuraminidase Substrate Promiscuity Permits a Mutant <i>Micromonospora viridifaciens</i> Enzyme To Synthesize Artificial Carbohydrates
Mutation of the nucleophilic amino
acid residue tyrosine to the
small nonpolar residue glycine (Y370G) in the active site of <i>Micromonospora viridifaciens</i> neuraminidase (<i>Mv</i>NA) produces an efficient catalyst for the transfer of <i>N</i>-acetylneuraminic acid from an artificial substrate (i.e., phenyl <i>N</i>-acetyl-β-d-neuraminide) to a sugar acceptor
(e.g., d-lactose, d-glucose, d-mannose, d-raffinose, d-allose, or d-fructose) to give <i>N</i>-acetyl-α-neuraminide coupled carbohydrate products.
In addition, this mutant enzyme (<i>Mv</i>NA Y370G) catalyzes
the transfer of a sugar residue from the artificial substrate 2-fluorophenyl <i>N</i>-acetyl-β-d-neuraminide to methyl glycopyranoside
acceptors. Interestingly, when trans-glycosylation reactions are conducted
in aqueous solutions containing 30% (v/v) acetonitrile, the α-anomeric
acceptors of methyl glucopyranoside and galactopyranoside generate
higher product yields than do their corresponding β-anomers.
Specifically, a 64 h reaction with 2-fluorophenyl <i>N</i>-acetyl-β-d-neuraminide as the limiting reagent and
the acceptors methyl α-d-galactopyranoside, methyl
α-d-glucopyranoside, or methyl α-d-mannopyranoside
gives trans-glycosylation product yields of 22%, 31%, or 34%, respectively.
With methyl α-d-galactopyranoside as the acceptor,
trans-glycosylations catalyzed by both <i>Mv</i>NA Y370G
and a 2,6-sialyltransferase yield identical products, which we identified
as methyl <i>N</i>-acetyl-α-d-neuraminyl-(2
→ 6)-α-d-galactopyranoside. The <i>Mv</i>NA Y370G-catalyzed coupling of <i>N</i>-acetylneuraminic
acid to these three methyl α-d-glycopyranoside acceptors
is favored by factors of 18–27-fold over the competing hydrolysis
reaction. These coupling efficiencies likely arise from nonselective
interactions between the acceptor glycopyranoside and <i>Mv</i>NA Y370G, which preferentially places a carbohydrate hydroxyl group
rather than water in close proximity to the active site where this
functionality intercepts the nascent neuraminyl oxacarbenium ion that
is formed during cleavage of the glycosidic bond in the aryl <i>N</i>-acetyl-β-d-neuraminide donor. The ability
to transfer <i>N</i>-acetylneuraminic acid from a stable
and readily accessible donor to acceptor carbohydrates that are not
substrates for sialyltransferases is one step on the path for the
production of pseudohuman glycoproteins from nonmammalian cell lines
Kinetic and structural evaluation of selected active site mutants of the Aspergillus fumigatus KDNase (sialidase)
Aspergillus fumigatus is an airborne fungal pathogen. We previously cloned and characterized an exo-sialidase from A. fumigatus and showed that it preferred 2-keto-3-deoxynononic acid (KDN) as a substrate to N-acetylneuraminic acid (Neu5Ac). The purpose of this study was to investigate the structure-function relationships of critical catalytic site residues. Site-directed mutagenesis was used to create three mutant recombinant enzymes: the catalytic nucleophile (Y358H), the general acid/base catalyst (D84A), and an enlargement of the binding pocket to attempt to accommodate the N-acetyl group of Neu5Ac (R171L). Crystal structures for all enzymes were determined. The D84A mutation had an effect in decreasing the activity of AfKDNase that was stronger than that of the same mutation in the structurally similar sialidase from the bacterium Micromonospora viridifaciens. These data suggest that the catalytic acid is more important in the reaction of AfKDNase and that catalysis is less dependent on nucleophilic or electrostatic stabilization of the developing positive charge at the transition state for hydrolysis. Removal of the catalytic nucleophile (Y358H) significantly lowered the activity of the enzyme, but this mutant remained a retaining glycosidase as demonstrated by nuclear magnetic resonance spectroscopic analysis. This is a novel finding that has not been shown with other sialidases. Kinetic activity measured at pH 5.2 revealed that R171L had higher activity on a Neu5Ac-based substrate than wild-type KDNase; hence, leucine in place of arginine in the binding pocket improved catalysis toward Neu5Ac substrates. Hence, whether a sialidase is primarily a KDNase or a neuraminidase is due in part to the presence of an amino acid that creates a steric clash with the N-acetyl group
Kinetic and structural evaluation of selected active site mutants of the Aspergillus fumigatus KDNase (sialidase)
Aspergillus fumigatus is an airborne fungal pathogen. We previously cloned and characterized an exo-sialidase from A. fumigatus and showed that it preferred 2-keto-3-deoxynononic acid (KDN) as a substrate to N-acetylneuraminic acid (Neu5Ac). The purpose of this study was to investigate the structure-function relationships of critical catalytic site residues. Site-directed mutagenesis was used to create three mutant recombinant enzymes: the catalytic nucleophile (Y358H), the general acid/base catalyst (D84A), and an enlargement of the binding pocket to attempt to accommodate the N-acetyl group of Neu5Ac (R171L). Crystal structures for all enzymes were determined. The D84A mutation had an effect in decreasing the activity of AfKDNase that was stronger than that of the same mutation in the structurally similar sialidase from the bacterium Micromonospora viridifaciens. These data suggest that the catalytic acid is more important in the reaction of AfKDNase and that catalysis is less dependent on nucleophilic or electrostatic stabilization of the developing positive charge at the transition state for hydrolysis. Removal of the catalytic nucleophile (Y358H) significantly lowered the activity of the enzyme, but this mutant remained a retaining glycosidase as demonstrated by nuclear magnetic resonance spectroscopic analysis. This is a novel finding that has not been shown with other sialidases. Kinetic activity measured at pH 5.2 revealed that R171L had higher activity on a Neu5Ac-based substrate than wild-type KDNase; hence, leucine in place of arginine in the binding pocket improved catalysis toward Neu5Ac substrates. Hence, whether a sialidase is primarily a KDNase or a neuraminidase is due in part to the presence of an amino acid that creates a steric clash with the N-acetyl group
C2-Oxyanion Neighboring Group Participation: Transition State Structure for the Hydroxide-Promoted Hydrolysis of 4‑Nitrophenyl α‑d‑Mannopyranoside
The hydroxide-catalyzed
hydrolysis of aryl 1,2-<i>trans</i>-glycosides proceeds
through a mechanism involving neighboring group
participation by a C2-oxyanion and rate-limiting formation of a 1,2-anhydro
sugar (oxirane) intermediate. The transition state for the hydroxide-catalyzed
hydrolysis of 4-nitrophenyl α-d-mannopyranoside in
aqueous media has been studied by the use of multiple kinetic isotope
effect (KIE) measurements in conjunction with <i>ab initio</i> theoretical methods. The experimental KIEs are C1-<sup>2</sup>H
(1.112 ± 0.004), C2-<sup>2</sup>H (1.045 ± 0.005), anomeric
1-<sup>13</sup>C (1.026 ± 0.006), C2-<sup>13</sup>C (0.999 ±
0.005), leaving group oxygen 2-<sup>18</sup>O (1.040 ± 0.012),
and C2-<sup>18</sup>O (1.044 ± 0.006). The transition state for
the hydrolysis reaction was modeled computationally using the experimental
KIE values as constraints. Taken together, the reported kinetic isotope
effects and computational modeling are consistent with the reaction
mechanism involving rate-limiting formation of a transient oxirane
intermediate that opens in water to give α-d-mannopyranose.
The transition state has significant nucleophilic participation by
the C2-alkoxide, an essentially cleaved glycosidic bond, and a slight
shortening of the endocyclic C1–O5 bond. The TS is late, consistent
with the large, normal C2-<sup>18</sup>O isotope effect
Kinetic and Structural Evaluation of Selected Active Site Mutants of the <i>Aspergillus fumigatus</i> KDNase (Sialidase)
<i>Aspergillus fumigatus</i> is an airborne fungal pathogen.
We previously cloned and characterized an <i>exo</i>-sialidase
from <i>A. fumigatus</i> and showed that it preferred 2-keto-3-deoxynononic
acid (KDN) as a substrate to <i>N</i>-acetylneuraminic acid
(Neu5Ac). The purpose of this study was to investigate the structure–function
relationships of critical catalytic site residues. Site-directed mutagenesis
was used to create three mutant recombinant enzymes: the catalytic
nucleophile (Y358H), the general acid/base catalyst (D84A), and an
enlargement of the binding pocket to attempt to accommodate the <i>N</i>-acetyl group of Neu5Ac (R171L). Crystal structures for
all enzymes were determined. The D84A mutation had an effect in decreasing
the activity of AfKDNase that was stronger than that of the same mutation
in the structurally similar sialidase from the bacterium <i>Micromonospora
viridifaciens</i>. These data suggest that the catalytic acid
is more important in the reaction of AfKDNase and that catalysis is
less dependent on nucleophilic or electrostatic stabilization of the
developing positive charge at the transition state for hydrolysis.
Removal of the catalytic nucleophile (Y358H) significantly lowered
the activity of the enzyme, but this mutant remained a retaining glycosidase
as demonstrated by nuclear magnetic resonance spectroscopic analysis.
This is a novel finding that has not been shown with other sialidases.
Kinetic activity measured at pH 5.2 revealed that R171L had higher
activity on a Neu5Ac-based substrate than wild-type KDNase; hence,
leucine in place of arginine in the binding pocket improved catalysis
toward Neu5Ac substrates. Hence, whether a sialidase is primarily
a KDNase or a neuraminidase is due in part to the presence of an amino
acid that creates a steric clash with the <i>N</i>-acetyl
group
Both Chemical and Non-Chemical Steps Limit the Catalytic Efficiency of Family 4 Glycoside Hydrolases
The
glycoside hydrolase family 4 (GH4) α-galactosidase from <i>Citrobacter freundii</i> (MelA) catalyzes the hydrolysis of
fluoro-substituted phenyl α-d-galactopyranosides by
utilizing two cofactors, NAD<sup>+</sup> and a metal cation, under
reducing conditions. In order to refine the mechanistic understanding
of this GH4 enzyme, leaving group effects were measured with various
metal cations. The derived β<sub>lg</sub> value on <i>V</i>/<i>K</i> for strontium activation is indistinguishable
from zero (0.05 ± 0.12). Deuterium kinetic isotope effects (KIEs)
were measured for the activated substrates 2-fluorophenyl and 4-fluorophenyl
α-d-galactopyranosides in the presence of Sr<sup>2+</sup>, Y<sup>3+</sup>, and Mn<sup>2+</sup>, where the isotopic substitution
was on the carbohydrate at C-2 and/or C-3. To determine the contributing
factors to the virtual transition state (TS) on which the KIEs report,
kinetic isotope effects on isotope effects were measured on these
KIEs using doubly deuterated substrates. The measured <sup>D</sup><i>V</i>/<i>K</i> KIEs for MelA-catalyzed hydrolysis
of 2-fluorophenyl α-d-galactopyranoside are closer
to unity than the measured effects on 4-fluorophenyl α-d-galactopyranoside, irrespective of the site of isotopic substitution
and of the metal cation activator. These observations are consistent
with hydride transfer at C-3 to the on-board NAD<sup>+</sup>, deprotonation
at C-2, and a non-chemical step contributing to the virtual TS for <i>V</i>/<i>K</i>
Novel small molecules potentiate premature termination codon readthrough by aminoglycosides
International audienceNonsense mutations introduce premature termination codons and underlie 11% of genetic disease cases. High concentrations of aminoglycosides can restore gene function by eliciting premature termination codon readthrough but with low efficiency. Using a high-throughput screen, we identified compounds that potentiate readthrough by aminoglyco-sides at multiple nonsense alleles in yeast. Chemical optimization generated phthalimide derivative CDX5-1 with activity in human cells. Alone, CDX5-1 did not induce readthrough or increase TP53 mRNA levels in HDQ-P1 cancer cells with a homozygous TP53 nonsense mutation. However, in combination with aminoglycoside G418, it enhanced readthrough up to 180-fold over G418 alone. The combination also increased readthrough at all three nonsense codons in cancer cells with other TP53 nonsense mutations, as well as in cells from rare genetic disease patients with nonsense mutations in the CLN2, SMARCAL1 and DMD genes. These findings open up the possibility of treating patients across a spectrum of genetic diseases caused by nonsense mutations